SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-019913
Filing Date
2018-08-07
Accepted
2018-08-07 16:06:46
Documents
73
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20180630.htm 10-Q 2153969
2 EX-31.1 flxn-ex311_6.htm EX-31.1 10029
3 EX-31.2 flxn-ex312_8.htm EX-31.2 10105
4 EX-32.1 flxn-ex321_7.htm EX-32.1 9107
  Complete submission text file 0001564590-18-019913.txt   7524175

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT flxn-20180630.xml EX-101.INS 1605568
6 XBRL TAXONOMY EXTENSION SCHEMA flxn-20180630.xsd EX-101.SCH 54429
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20180630_cal.xml EX-101.CAL 56108
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20180630_def.xml EX-101.DEF 171671
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20180630_lab.xml EX-101.LAB 424964
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20180630_pre.xml EX-101.PRE 324312
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 18997989
SIC: 2834 Pharmaceutical Preparations